Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: U.S.-EU GMP Mutual Recognition

Executive Summary

U.S.-EU GMP Mutual Recognition: Negotiations are expected to recommence the week of Jan. 27 in Washington, D.C., after stumbling early in the month when the EU Commission expressed reservations about exchanging inspection reports under any MRA. The EU also called for shortening the equivalency determination period from 3 years to 18 months. Negotiators had believed a compromise was reached at a Chicago meeting of the Trans-Atlantic Business Dialogue Nov. 8-9, and had vowed to complete an MRA by the end of January ("The Pink Sheet," Nov. 18, 1996, T&G-13)...

Latest Headlines
See All
UsernamePublicRestriction

Register

PS029578

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel